Erythrocyte membrane and hemorheologic determinants

Erythrocyte membrane and hemorheologic determinants refer to the structural components of red blood cells and the physical properties of blood that influence its flow through the vasculature. The erythrocyte membrane is a specialized protein-lipid complex that provides the durability and flexibility necessary for cells to survive in circulation and squeeze through narrow capillaries (Mohandas & Gallagher, 2008). Hemorheologic determinants include blood viscosity, plasma viscosity, and erythrocyte deformability and aggregation, which collectively dictate the resistance to blood flow (Baskurt & Meiselman, 2003). In diseases like peripheral artery disease or sickle cell anemia, these determinants are often compromised, leading to impaired microcirculation and tissue ischemia. Therapeutic agents such as pentoxifylline are used to improve these parameters by increasing RBC flexibility and reducing blood viscosity, although they act through pleiotropic effects rather than a single molecular target (Ward & Clissold, 1987). As such, this term describes a physiological state and cellular mechanics rather than a specific protein or receptor. Monitoring these determinants is essential for assessing the efficacy of hemorheologic therapies in clinical settings.

Other names

Red blood cell rheologyBlood viscosity factorsErythrocyte deformabilityHemorheological parametersRBC membrane mechanics

Improvement of erythrocyte deformability, reduction of blood viscosity, and inhibition of erythrocyte aggregation and platelet adhesion through modulation of intracellular cyclic nucleotide levels (StatPearls, 2023).